The XDR-TB emergency: Answers from the scientific community;Emergenza XDR-TB: Le risposte della comunità scientifica

Rassegna di Patologia dell'Apparato Respiratorio

Volumn 24, Issue 5, 2009, Pages 319-324

  Migliori, Giovanni Battista ^a   Centis, Rosella ^a   D'Ambrosio, Lia ^a   Besozzi, Giorgio ^b   Sotgiu, Giovanni ^c  

^a IRCCS   (Italy)

^b Ospedale E Morelli   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

Author keywords

Microbiological diagnosis; Outcomes; Treatment efficacy; XDR TB

Indexed keywords

LINEZOLID; TUBERCULOSTATIC AGENT;

ARTICLE; EARLY DIAGNOSIS; EMERGENCY CARE; EPIDEMIOLOGICAL DATA; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HEALTH PROGRAM; HUMAN; LABORATORY TEST; MEDICAL LITERATURE; METHODOLOGY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; TREATMENT DURATION;

EID: 74549145635     PISSN: 00339563     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. World Health Organization. Global Tuberculosis Control 2008, Surveillance, Planning Financing: WHO Report 2008. WHO/HTM/TB2008.393. Geneva, World Health Organization, 2008.
2. Zignol M, Hosseini MS, Wright A, et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006;194:479-85.
3. Aziz MA, Wright A, Laszlo A, et al. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 2006;368:2142-54.
4. Espinal MA, Laszlo A, Simonsen L, et al. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001;344:1294-303.
5. Raviglione MC, Uplekar MW. WHO's new Stop TB Strategy. Lancet 2006;367:952-55.
6. World Health Organization (WHO). Anti-tuberculosis drug resistance in the world. Fourth global report. WHO/HTM/TB/2008.394. Geneva, World Health Organization, 2008.
7. World Health Organization. Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Weekly Epidemiol Records 2006;81:430-2.
8. Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs- worldwide. MMWR 2006;55:301-5.
9. Gandhi NR, Moll A, Sturm AW et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368:1575-80.
10. Migliori GB, Ortmann J, Girardi E, et al. Extensively drug-resistant tuberculosis, Italy and Germany. Emerg Infect Dis 2007;13:780-2.
11. Migliori GB, Besozzi G, Girardi E, et al. Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J 2007;30:623-26.
12. Kim HR, Hwang SS, Kim HJ, et al. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis. Clin Infect Dis 2007;45:1290-5.
13. Mitnick CD, Shin SS, Seung KJ, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 2008;359:563-74.
14. Chan ED, Strand MJ, Iseman MD. Treatment outcomes in extensively resistant tuberculosis. N Engl J Med 2008;359:657-9.
15. B. Eker, J. Ortmann, G.B. Migliori, et al. Multidrug- and extensively-drug resistant tuberculosis: a TBNET survey in Germany. Emerg Infect Dis 2008;14:1700-6.
16. Keshavjee S, Gelmanova IY, Farmer PE, et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 2008;372:1403-9.
17. Kwon YS, Kim YH, Suh GY, et al. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis 2008;47:496-502.
18. Lai CC, Tan CK, Huang YT, et al. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan. Clin Infect Dis 2008;47:e57-63.
19. Banerjee R, Allen J, Westenhouse J, et al. Extensively drug-resistant tuberculosis in California, 1993-2006. Clin Infect Dis 2008;47:450-7.
20. Bonilla CA, Crossa A, Jave HO, et al. Management of extensively drug-resistant tuberculosis in Peru: cure is possible. PLoS ONE 2008;3:e2957.